Ajinomoto Bio-Pharma Services

Ajinomoto Bio-Pharma Services, founded in 1998, operates as a prominent global contract development and manufacturing organization (CDMO) within the pharmaceutical and healthcare sectors. The company specializes in providing comprehensive process development, regulatory-compliant manufacturing, and advanced fill-finish services for both small and large molecule active ingredients. By leveraging proprietary technology platforms, the firm supports biotech and pharmaceutical partners in advancing drug candidates from early-stage research through to full-scale commercial production.

The organization maintains a robust operational footprint with 4 global locations across North America, Europe, and Asia. With a workforce of 1,000-5,000 employees, the company emphasizes high-quality standards and adherence to global regulatory requirements. Meet Ajinomoto Bio-Pharma Services's team to understand the technical expertise driving their integrated contract development and biopharmaceutical manufacturing services. Their operational model is designed to facilitate seamless transitions for clients throughout the drug development lifecycle.

Ajinomoto Bio-Pharma Services distinguishes itself through its focus on innovation and specialized aseptic fill-finish capabilities. The company serves as a critical partner for organizations developing advanced therapies, ensuring that complex biopharmaceutical products meet stringent quality benchmarks. By integrating manufacturing services with deep scientific expertise, the firm continues to expand its influence in the global life sciences market. Their commitment to excellence in contract manufacturing supports the rapid delivery of essential medical treatments to patients worldwide.